Homeobox genes and other developmental transcription factors become preferential targets of de novo methylation in DCIS, consistent with previous associations between homeobox gene methylation and recurrence in invasive breast cancers [21, 27]. This evidence concerns the gene LBX1 and ductal breast carcinoma in situ.